Agile Therapeutics
AGRX
₹129.19
Share price
0.00%
Change (1 day)
157.58%
Change (1 year)
Categories
Agile Therapeutics (AGRX) - Cash on Hand
Cash on Hand as of June 2024 : ₹0.24 Billion
According to Agile Therapeutics
's latest financial reports the company has ₹0.24 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Agile Therapeutics - Cash on Hand chart (from 2013 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | ₹0.43 B | -69.53% |
| 2021-12-31 | ₹1.42 B | -64.23% |
| 2020-12-31 | ₹3.98 B | 62.02% |
| 2019-12-31 | ₹2.45 B | 347.89% |
| 2018-12-31 | ₹0.54 B | -76.09% |
| 2017-12-31 | ₹2.29 B | -30.71% |
| 2016-12-31 | ₹3.31 B | 44.93% |
| 2015-12-31 | ₹2.28 B | -10.25% |
| 2014-12-31 | ₹2.54 B | 1844.73% |
| 2013-12-31 | ₹0.13 B | -88.05% |
| 2012-12-31 | ₹1.09 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | ₹0.43 B | 77.21% | 🇺🇸 USA |
 | N/A | N/A | 🇺🇸 USA |
 | ₹2.098 T | 860,925.28% | 🇺🇸 USA |
 | ₹1.171 T | 480,553.09% | 🇺🇸 USA |
 | ₹1.751 T | 718,895.79% | 🇺🇸 USA |